(0)

Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Renaissance London Heathrow Hotel

Oct 09, 2018 8:00 AM - Oct 10, 2018 5:30 PM

Bath Road, Hounslow, Middlesex, TW6 2AQ, United Kingdom

Value, Access, and Regulatory Strategy Conference

Paving the Way to the Future by Building Bridges

Back to Agenda

Session 5: Acceptance of Evidence in Decision Making – Using Available Evidence at Launch for Access Decisions

Speaker(s)

William Malbecq, DrSc

Using RCT Data for HTA Strategies - Best Available Evidence at Launch to Qualify Benefits of New Medicines

William Malbecq, DrSc

MSD, Belgium

Head of Biostatistics Europe

Anja Schiel, PhD

Experience from NoMA

Anja Schiel, PhD

Norwegian Medicines Agency (NoMA), Norway

Special Advisor, Lead Methodologist; Leader international HTA (iHTA) NoMA

Solange Corriol-Rohou, DrMed, MD, PhD

Regulatory Tools to drive post-licensing evidence generation

Solange Corriol-Rohou, DrMed, MD, PhD

AstraZeneca , France

Senior Director, Global Regulatory Affairs & Policy, R&D, Europe

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.